0001567619-21-019159.txt : 20211102 0001567619-21-019159.hdr.sgml : 20211102 20211102124424 ACCESSION NUMBER: 0001567619-21-019159 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211102 DATE AS OF CHANGE: 20211102 EFFECTIVENESS DATE: 20211102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medcura, Inc. CENTRAL INDEX KEY: 0001672180 IRS NUMBER: 260649449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-419490 FILM NUMBER: 211370039 BUSINESS ADDRESS: STREET 1: 387 TECHNOLOGY DR. CITY: COLLEGE PARK STATE: MD ZIP: 20742 BUSINESS PHONE: 3014053585 MAIL ADDRESS: STREET 1: 387 TECHNOLOGY DR. CITY: COLLEGE PARK STATE: MD ZIP: 20742 FORMER COMPANY: FORMER CONFORMED NAME: gel-e, Inc. DATE OF NAME CHANGE: 20160919 FORMER COMPANY: FORMER CONFORMED NAME: Remedium Technologies, INC. DATE OF NAME CHANGE: 20160413 D 1 primary_doc.xml X0708 D LIVE 0001672180 Medcura, Inc. 5650 Rivertech Court Suite S. Riverdale MD MARYLAND 20737 (240) 684-8801 DELAWARE Remedium Technologies, Inc. gel-e, Inc. Remedium Technologies, INC. Corporation true Matthew Dowling 5650 Rivertech Court Suite S. Riverdale MD MARYLAND 20737 Executive Officer Director Chief Scientific Officer Larry Tiffany 5650 Rivertech Court Suite S. Riverdale MD MARYLAND 20737 Executive Officer Director Chief Executive Officer Jim Buck 5650 Rivertech Court Suite S. Riverdale MD MARYLAND 20737 Director Rich Vincent 5650 Rivertech Court Suite S. Riverdale MD MARYLAND 20737 Executive Officer Chief Financial Officer Biotechnology Decline to Disclose 06b false 2021-10-15 false true true true true true Convertible Promissory Notes, including Common Stock or Preferred Stock into which the notes can be converted. false 0 5761644 3490000 2271644 false 45 0 0 0 false Medcura, Inc. /s/ Larry Tiffany Larry Tiffany Chief Executive Officer 2021-11-01